Data & digital
Data & digital
Support the use of data and digital interventions to improve patient outcomes. Using technology to transform health services to improve clinical outcomes, increased access to services and patient self-management.
The UK is uniquely placed to realise the potential of data and digital in healthcare, including access to at scale data in the NHS, real world evidence and novel applications. This is supported by an ambitious culture and continuously improving system for innovation underpinned by world leading talent.
NHSx is a new joint unit to combine talent in industry, government and NHS to drive the benefits of modern technology to every patient and clinician. It brings together for the first time the policy implementation and change levers across the entire NHS and others to build world class digital services and improve care for patients.
Data & digital
The NHS’s strategy — the Five Year Forward View — puts patient empowerment and digital technology at the heart of responding to the pressures on the system.
It goes for a whole system approach to transformation in everything we do in healthcare. We want faster, better quality, safer, innovative and better-informed patients.
The UK is already home to world leading health tech companies and has pioneered innovative healthcare in a number of areas.
But the UK also has a lot of experience on support on digital transformation and tying technology to improve patient outcomes.
UK organisations can provide:
- Advisory support to develop nationwide, regional and local digital health strategies.
- Policy support for using data for research, service planning and direct care.
- Consultancy support for implanting digital health systems –electronic patient records.
- Transformation of health services through technology –remote monitoring.
- Designing innovations to support screening and self-management of disease.
Data & digital
Organisations that specialise in data & digital
→
→
→
→
→
→
→
→
→
→
→
→
→
→
Data & digital
Case study: Vita Healthcare Solutions
Vita are experts in identifying and removing barriers so health systems can adopt and accelerate the right innovation.
Our evidence-based approach is grounded in our work across the entirety of the Imperial College London ecosystem where we were simultaneously at Imperial College Health Partners, the Academic Health Science Network, the National Institute for Health Research with Prof George Hanna, the MedTech SuperConnector (accelerator programme funded by Research England and delivered in partnership with The Francis Crick Institute while based at imperial) as well as at Imperial College London itself at both the Business and Medical schools.
This is supplemented by our partners including the National Association of Primary care. This approach involves careful matching of system needs to the offers of innovators so decisions to collaborate are ‘de-risked’. We also simplify language and ensure capital investment can flow to the innovations that require it to flourish and gain adoption.
We work with all types of stakeholders from payors, investors, innovators, Governments and Ministries of Health as well as MNCs.
Research England identified a need for technology acceleration of diagnostic devices at the outset of the Covid pandemic. Vita designed and delivered a new and unique accelerator programme in conjunction with the NIHR London In Vitro Diagnostics Co-operative and the MedTech SuperConnector to identify and accelerate promising mid-stage research projects to market and scale. Vita also supported the innovator firms with coaching and mentoring to facilitate market access and the successful programme is now being repurposed into a new Masters Degree at Imperial College London.